AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: Phase III Clinical Trial Investor Webinar, page-41

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,650 Posts.
    lightbulb Created with Sketch. 777
    Paul has stated a few times that he knows news flow has been poor and that he takes responsibility for it. One and a half months in and (aside from mandatory reports) no news. He needs to be more active, promoting and selling the trial if for no other reason than to recruit.
    Also what happened in the USA? Some accountability for those trips needs to happen.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.